Primary prevention strategies, including lifestyle modifications and treatment of risk factors such as hypertension and type 2 diabetes, are essential to reduce the growing incidence of heart failure.
Do primary prevention strategies reduce incident heart failure in the general population and individuals with cardiovascular risk factors?
This HFA/EAPC position paper provides a comprehensive framework for the primary prevention of heart failure through risk factor modification, lifestyle interventions, and targeted pharmacotherapy such as SGLT2 inhibitors.
The heart failure epidemic is growing and its prevention, in order to reduce associated hospital readmission rates and its clinical and economic burden, is a key issue in modern cardiovascular medicine. The present position paper aims to provide practical evidence-based information to support the implementation of effective preventive measures. After reviewing the most common risk factors, an overview of the population attributable risks in different continents is presented, to identify potentially effective opportunities for prevention and to inform preventive strategies. Finally, potential interventions that have been proposed and have been shown to be effective in preventing heart failure are listed.
Piepoli et al. (Sat,) conducted a review in Heart failure. Primary prevention strategies, including lifestyle modifications and treatment of risk factors such as hypertension and type 2 diabetes, are essential to reduce the growing incidence of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: